Abstract:Innate immune response provides the host with an early protection barrier against invading pathogens and helps shape the nature and quality of the subsequent adaptive immune response of the host. Ubiquitin-specific protease 18 (USP18 ) plays an important role in the host innate immune response. This role is mediated both via its enzymatic and non-enzymatic functions. First, conjugation of ISG15 to its targets is counteracted by the enzymatic activity of USP18. Second, the C terminus of USP18 can bind to the type I interferon receptor subunit (IFNAR2) and compete with JAK1 receptor binding which inhibits the activation of the receptor associated kinases JAK1 and TYK2. While USP18 deficiency prolonged phosphorylation of STATs and increased ISG expression in response to IFN, forced expression of either wild type or enzymatically inactive mutatant USP18 in the cells reduces the phosphorylation level of STATs and the downstream transcriptional events. USP18 knockout mice have a greater resistance to viral/bacterial infection in several experimental mouse models. In addition, USP18 was found to inhibit IFNsignaling but did not inhibit IFN, IFN, IL-6, or IL-12 signaling pathways. Results from our previous study demonstrated that USP18 was overexpressed in the liver biopsy specimens of HCV patients who do not respond to the combination therapy of pegylated interferon-alpha (IFN) and ribavirin (RBV). We also found that increased expression of either wild type USP18 or catalytically inactive mutant USP18 blunted the effect of both type I and type III IFNs and promoteded HCV production in the J6/JFH1 culture system. Another study suggested that HBV infection is more rapidly cleared if USP18 expression level is reduced. Most recently it has been shown that USP18 may play an important role in mediating inflammation. Inhibition of USP18 leads to upregulation of several pro-inflammatory chemokine, including CCL5, CXCL10 and IL-15, via induction of the STAT signaling pathway and increases IFN induced beta cell apoptosis. Taken together, small molecule inhibitors against USP18 might be a viable approach to potentiate the host innate immunity leading to a better control of viral infections.

USP18 positively regulates innate antiviral immunity by promoting K63-linked polyubiquitination of MAVS

MAVS-loaded unanchored Lys63-linked polyubiquitin chains activate the RIG-I-MAVS signaling cascade

USP18 recruits USP20 to promote innate antiviral response through deubiquitinating STING/MITA

USP13 Cooperates with MARCH8 to Inhibit Antiviral Signaling by Targeting MAVS for Autophagic Degradation in Teleost

USP21 Negatively Regulates Antiviral Response by Acting As a RIG-I Deubiquitinase

USP26 suppresses type I interferon signaling by targeting TRAF3 for deubiquitination

USP20 Promotes Cellular Antiviral Responses via Deconjugating K48-Linked Ubiquitination of MITA

USP44 positively regulates innate immune response to DNA viruses through deubiquitinating MITA

Induction of USP25 by viral infection promotes innate antiviral responses by mediating the stabilization of TRAF3 and TRAF6

USP49 negatively regulates cellular antiviral responses via deconjugating K63-linked ubiquitination of MITA

PPM1A Silences Cytosolic RNA Sensing and Antiviral Defense Through Direct Dephosphorylation of MAVS and TBK1.

MicroRNA-33/33* Inhibit the Activation of MAVS Through AMPK in Antiviral Innate Immunity

Deubiquitinase USP47 attenuates virus-induced type I interferon signaling

UBL7 enhances antiviral innate immunity by promoting Lys27-linked polyubiquitination of MAVS

E3 ligase ASB3 downregulates antiviral innate immunity by targeting MAVS for ubiquitin-proteasomal degradation

MAVS deSUMOylation by SENP1 inhibits its aggregation and antagonizes IRF3 activation

MAVS promotes interferon signaling in RNA virus infection by ZUFSP-mediated chromatin regulation

The role of USP 18 in interferon signaling and inflammation

Palmitoylation acts as a checkpoint for MAVS aggregation to promote antiviral innate immune responses

Dual modifying of MAVS at lysine 7 by SIRT3-catalyzed deacetylation and SIRT5-catalyzed desuccinylation orchestrates antiviral innate immunity

Regulation of MAVS Expression and Signaling Function in the Antiviral Innate Immune Response